ABSTRACT We suggest a novel approach to enhancing antimicrobial drug action by utilizing engineered peptide conjugates. Our most potent conjugates,[fMLF] PMBN and [fMLF] PMEN, are nonapeptides derived from polymyxin B's (PMB's) cyclic moiety (Thr-Dab- cyclo [Dab-Dab-d-Phe-Leu-Dab-Dab-Thr], where Dab is 2, 4-diaminobutyric acid) and polymyxin E's (PME's) cyclic moiety (Thr-Dab-cyclo [Dab-Dab-d-Leu-Leu-Dab-Dab-Thr]), ...
[Okimura, Keiko; Ohki, Kazuhiro; Sato, Yuki; Ohnishi, Kuniharu; Uchida, Yoshiki; Sakura, Naoki Bulletin of the Chemical Society of Japan, 2007 , vol. 80, # 3 p. 543 - 552]